British Man Tests Positive for Ebola in DRC; UK Procedures Activated

According to BBC UK, a British man who has tested positive for Ebola in the Democratic Republic of Congo is set to be transported back to the UK. This incident represents the initial confirmed instance of a UK national contracting Ebola during the most recent outbreak of the rare and fatal virus in the DRC, an outbreak that has resulted in more than 5,000 fatalities to date.

It is currently unknown when this flight will occur. A spokesperson for the UK government stated that there are established protocols for managing such situations and that these procedures have been initiated. The spokesperson also noted that the risk posed to the general public in the UK remains low.

Reuters reported that the infected man is a healthcare worker, citing an internal document that BBC News has not seen. Imported cases of Ebola in the UK are exceptionally rare and have not resulted in any deaths.

Historically, there have been only four confirmed instances of the virus in the UK: one in 1976, which stemmed from a laboratory incident, and three cases involving health workers who were responding to an outbreak in West Africa between 2014 and 2015.

Regarding the ongoing situation, the outbreak centered in the DRC is being fueled by the Bundibugyo variant of the virus. Since the outbreak began in May, there have been over 10,000 confirmed cases in the DRC, making it the second most deadly recorded infection period, following the outbreak in West Africa. It has since become the deadliest in the country's history, with a reported fatality rate of 48.6% at the close of last month.

Ebola is capable of causing severe illness and death. Initial symptoms can include vomiting and diarrhea, but the condition may advance to internal bleeding and organ failure. The virus transmits from one individual to another through contact with infected bodily fluids, such as blood or vomit.

While there is no approved vaccine, experts from the World Health Organisation have advised adding two new candidate drugs to an ongoing clinical trial. These vaccines, one developed by the University of Oxford and the Serum Institute of India, and another by the company Moderna, will enter the trial once Congolese health authorities grant approval. This would be the first time vaccines specifically designed to protect against the Bundibugyo virus are tested during an active outbreak. Ebola cases have also been confirmed in Kenya, Uganda, and Nigeria since the outbreak.